4-羟基-2,6-二甲基-5-嘧啶乙酸 | 5536-40-3

• 物质功能分类: 医药中间体 - 杂环化合物 - 嘧啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 4-羟基-2,6-二甲基-5-嘧啶乙酸
• 中文别名: 2,6-二甲基-4-羟基-6-嘧啶乙酸
• 英文名称: (2,6-dimethyl-4-hydroxy-pyrimidin-5-yl)-acetic acid
• 英文别名: 4-Hydroxy-2,6-dimethyl-5-carboxymethyl-pyrimidin；(2,4-dimethyl-6-oxo-1,6-dihydro-pyrimidin-5-yl)-acetic acid；(2,6-Dimethyl-4-hydroxy-5-pyrimidinyl)-acetic acid；(4-Hydroxy-2,6-dimethyl-pyrimidin-5-yl)-acetic acid；2-(2,4-dimethyl-6-oxo-1H-pyrimidin-5-yl)acetic acid
• CAS: 5536-40-3
• 化学式: C₈H₁₀N₂O₃
• mdl: MFCD03192764
• 分子量: 182.179
• InChiKey: VOOQEOLOKRTHEB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.9
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.375
• 拓扑面积：
  78.8
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S39
• 危险类别码：
  R41
• 海关编码：
  2933599090

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : (4-Hydroxy-2,6-Dimethylpyrimidin-5-Yl)Acetic Acid
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xi Irritant R41
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

---

SECTION 3: Composition/information on ingredients
Substances
Molecular weight : 182,18 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
(4-Hydroxy-2,6-Dimethylpyrimidin-5-Yl)Acetic Acid
<= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
(4-Hydroxy-2,6-Dimethylpyrimidin-5-Yl)Acetic Acid
Xi, R41 <= 100 %

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
No data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Nature of decomposition products not known.
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Avoid
breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Storage class (TRGS 510): Non Combustible Solids
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour No data available
c) Odour Threshold No data available
d) pH No data available
e) Melting point/freezing No data available
point
f) Initial boiling point and No data available
boiling range
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower No data available
flammability or
explosive limits
k) Vapour pressure No data available
l) Vapour density No data available
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: n- No data available
octanol/water
p) Auto-ignition No data available
temperature
q) Decomposition No data available
temperature
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
Other safety information
No data available

---

SECTION 10: Stability and reactivity
Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
No data available
Hazardous decomposition products
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available

---

SECTION 12: Ecological information
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
Other adverse effects
No data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
No data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
No data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

---

SECTION 16: Other information
Full text of R-phrases referred to under sections 2 and 3
Xi Irritant
R41 Risk of serious damage to eyes.
Further information
Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  4-羟基-2,6-二甲基-5-嘧啶乙酸 在 盐酸 、 三氯氧磷 作用下， 以 甲苯 为溶剂， 反应 19.0h， 生成 (4-chloro-2,6-dimethyl-pyrimidin-5-yl)-acetic acid methyl ester
  参考文献：
  名称：

  Craig, G. Wayne; Eberle, Martin; Lamberth, Clemens, Journal fur Praktische Chemie (Weinheim), 2000, vol. 342, # 5, p. 504 - 507

  摘要：

  DOI：
• 作为产物：
  描述：

  乙酰丁二酸二甲酯 、 盐酸乙脒 在 sodium methylate 作用下， 以 甲醇 为溶剂， 反应 16.0h， 生成 4-羟基-2,6-二甲基-5-嘧啶乙酸
  参考文献：
  名称：

  Craig, G. Wayne; Eberle, Martin; Lamberth, Clemens, Journal fur Praktische Chemie (Weinheim), 2000, vol. 342, # 5, p. 504 - 507

  摘要：

  DOI：

文献信息

• [EN] NON-PEPTIDIC HETEROCYCLE-CONTAINING COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] COMPOSÉS NON PÉPTIDIQUES CONTENANT DES HÉTÉROCYCLES POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
  申请人：UNIV ALBERTA

  公开号：WO2020215157A1

  公开（公告）日：2020-10-29

  The present disclosure provides non-peptidic heterocycle-containing amylin receptor antagonist compounds, compositions that include the subject compounds, methods for preparing and using the amylin receptor antagonists, and compositions containing the amylin receptor antagonists for treating, preventing, or ameliorating Alzheimer's disease. Aspects of the present disclosure include a method of inhibiting activity of an amylin receptor by administering to a subject in need thereof a therapeutically effective amount of an amylin receptor antagonist.

  本公开提供了含非肽杂环的胰岛素类受体拮抗剂化合物，包括该类化合物的组合物，用于制备和使用胰岛素类受体拮抗剂的方法，以及含有胰岛素类受体拮抗剂的组合物，用于治疗、预防或改善阿尔茨海默病。本公开的方面包括通过向需要的受试者投与治疗有效量的胰岛素类受体拮抗剂来抑制胰岛素类受体活性的方法。
• Pyrimidinyl acrylic acid derivatives
  申请人：Sandoz Ltd.

  公开号：US05453427A1

  公开（公告）日：1995-09-26

  The invention discloses compounds of formula I It has now been found that compounds of formula I ##STR1## wherein R.sub.1 is hydrogen, methyl, ethyl or trifluoromethyl, and R.sub.2 is hydrogen, methyl, ethyl, C.sub.1-4 alkylthio, C.sub.1-4 alkoxy, or di-C.sub.1-4 alkylamino, and R.sub.3 is C.sub.1-10 alkyl, C.sub.1-10 haloalkyl, aryl, heteroaryl, aryl-C.sub.1-4 alkyl, heteroaryl-C.sub.1-4 alkyl, aryloxy-C.sub.1-4 alkyl, aryloxyaryl, arylaryl, heteroaryl, aryl-C.sub.1-4 alkoxyaryl, aryl-C.sub.1-4 alkoxy-C.sub.1-4 alkyl, heteroaryloxyaryl, aryloxy-C.sub.1-4 alkylaryl or aryl substituted by a group selected from --C(CH.sub.3).dbd.N--O--CH.sub.2 --aryl, --C(CH.sub.3).dbd.N--O--CH(CH.sub.3)--aryl, --C(CH.sub.3).dbd.N--C.sub.1-4 alkoxy, --C(CH.sub.3).dbd.N--C.sub.3-4 alkenyloxy,--C(CH.sub.3).dbd.N--C.sub.3-4 alkynyloxy, or --CH.sub.2 --O--N.dbd.C(CH.sub.3)--aryl, wherein each of the aromatic rings may be optionally substituted; the use of such compounds for the control of phytopathogens, compositions for facilitating such use, and the preparation of the compounds of fomula I.

  本发明公开了化合物I的公式。现在发现，化合物I的公式为： ##STR1## 其中，R1为氢、甲基、乙基或三氟甲基，R2为氢、甲基、乙基、C1-4烷基硫、C1-4烷氧基或双C1-4烷基氨基，R3为C1-10烷基、C1-10卤代烷基、芳基、杂环芳基、芳基-C1-4烷基、杂环芳基-C1-4烷基、芳氧基-C1-4烷基、芳氧基芳基、芳基芳基、杂环芳基、芳基-C1-4烷氧基芳基、芳基-C1-4烷氧基-C1-4烷基、杂环芳氧基芳基、芳氧基-C1-4烷基芳基或芳基被选择自--C(CH3)=N-O-CH2-芳基、--C(CH3)=N-O-CH(CH3)-芳基、--C(CH3)=N-C1-4烷氧基、--C(CH3)=N-C3-4烯氧基、--C(CH3)=N-C3-4炔氧基或--CH2-O-N=C(CH3)-芳基的基团取代的芳基，其中每个芳香环可以选择性地取代；使用这种化合物来控制植物病原体，为促进这种使用而制备的组合物以及化合物I的制备。
• Condensed pyrimidine derivatives and their use as angiotensine II antagonists
  申请人：AMERICAN HOME PRODUCTS CORPORATION

  公开号：EP0539086A2

  公开（公告）日：1993-04-28

  This invention relates to pyrrolo-, pyrido-, azepino-, and azocinopyrimidines of the general formula I useful for treating hypertension or congestive heart failure and for preventing or treating restenosis following angioplasty, to pharmaceutical compositions, and to methods for production thereof.

  本发明涉及通式 I 的吡咯并嘧啶、吡啶并嘧啶、氮杂环庚并嘧啶和氮杂环辛并嘧啶。 用于治疗高血压或充血性心力衰竭以及预防或治疗血管成形术后的再狭窄、药物组合物及其生产方法。
• Pyrimidinyl acrylic acid derivatives, process for their preparation and their use for the control of phytopathogens
  申请人：SANDOZ LTD.

  公开号：EP0634405A1

  公开（公告）日：1995-01-18

  Compounds of formula I wherein R₁is hydrogen, methyl, ethyl or trifluoromethyl, and R₂is hydrogen, methyl, ethyl, C₁₋₄alkylthio, C₁₋₄alkoxy, or di-C₁₋₄alkylamino, and R₃is C₁₋₁₀alkyl, C₁₋₁₀haloalkyl, aryl, heteroaryl, aryl-C₁₋₄alkyl, heteroaryl-C₁₋₄alkyl, aryloxy-C₁₋₄alkyl, aryloxyaryl, arylaryl, heteroaryl, aryl-C₁₋₄alkoxyaryl, aryl-C₁₋₄alkoxy-C₁₋₄alkyl, heteroaryloxyaryl, aryloxy-C₁₋₄alkylaryl or aryl substituted by a group selected from -C(CH₃)=N-O-CH₂-aryl, -C(CH₃)=N-O-CH(CH₃)-aryl, -C(CH₃)=N-C₁₋₄alkoxy, -C(CH₃)=N-C₃₋₄alkenyloxy, -C(CH₃)=N-C₃₋₄alkynyloxy, or -CH₂-O-N=C(CH₃)-aryl, wherein each of the aromatic rings may be optionally substituted; the use of such compounds for the control of phytopathogens, compositions for facilitating such use, and the preparation of the compounds of formula I.

  式 I 的化合物 式中 R₁ 是氢、甲基、乙基或三氟甲基，以及 R₂ 是氢、甲基、乙基、C₁₋₄烷硫基、C₁₋₄烷氧基或二₁₋₄烷基氨基，以及 R₃是 C₁₋₁₀烷基、C₁₋₁₀卤代烷基、芳基、杂芳基、芳基-C₁₋₄烷基、杂芳基-C₁₋₄烷基、芳氧基-C₁₋₄烷基、芳氧基芳基、芳芳基、杂芳基、芳基-C₁₋₄烷氧基芳基、芳基-C₁₋₄烷氧基-C₁₋₄烷基、杂芳氧基芳基、芳氧基-C₁₋₄烷芳基或被选自-C(CH₃)=N-O-CH₂-芳基、-C(CH₃)=N-O-CH(CH₃)-芳基、-C(CH₃)=N-C₁₋₄烷氧基的基团取代的芳基、-C(CH₃)=N-C₃₋₄烯氧基，-C(CH₃)=N-C₃₋₄炔氧基，或-CH₂-O-N=C(CH₃)-芳基，其中每个芳环可任选被取代； 将此类化合物用于控制植物病原体、促进此类用途的组合物，以及式 I 化合物的制备。
• MELIK-OGANDZHANYAN R. G.; XACHATRYAN V. EH.; MIRZOYAN V. S.; OXIKYAN V. M+, AJKAKAN KIMIAKAN AMSAGIR, ARM. XIM. ZH., 1979, 32, HO 1, 33-38
  作者：MELIK-OGANDZHANYAN R. G.、 XACHATRYAN V. EH.、 MIRZOYAN V. S.、 OXIKYAN V. M+

  DOI：——

  日期：——